Stay updated on Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded revision v3.4.2 to the study record history; removed the government funding lapse notice (v3.4.1).SummaryDifference0.7%

- Check21 days agoChange DetectedA site-wide Notice about funding-related data delays was added, and a new revision entry (v3.4.1) was introduced in the history.SummaryDifference0.7%

- Check28 days agoChange DetectedUI updates include a Show glossary option, color-coding explanations for additions and deletions, and updated revision metadata (v3.4.0). These are minor interface and version-tracking changes rather than changes to core study data or functionality.SummaryDifference1.0%

- Check42 days agoChange DetectedThe Record History now shows a new revision entry v3.3.4 and removes v3.3.3, affecting only the version history metadata.SummaryDifference0.1%

- Check64 days agoChange Detected- Revision: v3.3.3 added to the Record History; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history now includes a new entry 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1' entry.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.